The Broad Institute of Harvard, located in Cambridge, MA, is a renowned research institution dedicated to advancing the understanding of cancer through patient-oriented laboratory research. Led by Todd R. Golub, MD, the institute focuses on molecular investigations of clinical observations in cancer medicine to develop improved diagnostics and therapeutics, with a strong emphasis on genomic approaches such as gene expression profiling-based cancer classification.
Recognized for its groundbreaking work, the Broad Institute has received prestigious honors including membership in the National Academy of Medicine and awards from The American Society for Clinical Investigation. With a commitment to innovation and discovery, the institute continues to lead the way in cancer research and therapeutic development.
Generated from the website